BEAT (HeartBeam Corporation) צמיחת רווח למניה בשנה הנוכחית
HeartBeam, Inc. (BEAT) ensures seamless equipment assembly through diversified logistics and chip reserves. Demand for emergency cardiac diagnostics makes the business highly resilient to macroeconomic shocks. The company is advancing the commercialization of personal ECG devices for remote monitoring. This chart on GURU.Markets reflects changes in EPS compared to the same period last year, where the value 38.10 describes the current level.
פילוחי מדדים מקיפים ואנליטיקה עבור HeartBeam, Inc. (BEAT)
HeartBeam, Inc. (BEAT) focuses on the clinical validation of AI algorithms without utilizing merger deals. The year-over-year EPS growth rate reflects changes in net income per share, excluding market noise. This indicator measures the efficiency of capitalizing intellectual property into actual revenue. Analyzing the trajectory allows for an assessment of the company's pace toward the commercial phase. Investors use this trend to balance drawdown risks.
